New vaccine against Respiratory Syncytial Virus (RSV) elicits strong immune response
An experimental vaccine against respiratory syncytial virus (RSV), one of the leading causes of infectious disease deaths in infants, has shown early promise in a Phase 1 human clinical trial. A team of researchers, including ...
Aug 1, 2019
0
337